Cite
HARVARD Citation
Ferdinand, K. et al. (2016). Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events. Cardiovascular diabetology. 15 (1), pp. 1-12. [Online].